إعلان
إعلان
GPCR
Structure Therapeutics Inc. - ADR
68.11
USDبرعاية
-1.44
-2.07%
٠٢ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
67.90
-0.21
-0.31%
تقارير أرباح GPCR
النسبة الإيجابية المفاجئة
GPCR تفوق 1 من 12 آخر التقديرات.
8%
التقرير التالي
بيانات التقرير القادم
٢٥ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.40
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/+8.11%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/-42.03%
Structure Therapeutics Inc. - ADR earnings per share and revenue
On ٠٦ نوفمبر ٢٠٢٥, GPCR reported earnings of -0.37 USD per share (EPS) for Q3 25, missing the estimate of -0.35 USD, resulting in a -3.24% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -1.88% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 16 analysts forecast an EPS of -0.40 USD, with revenue projected to reach -- USD, implying an increase of 8.11% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
٢٢ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.57
الفعلي
-$0.73
مفاجئة
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
١٩ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.25
الفعلي
-$0.19
مفاجئة
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
٢٣ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.12
الفعلي
-$0.06
مفاجئة
+50.98%
الأسئلة الشائعة
What were Structure Therapeutics Inc. - ADR's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Structure Therapeutics Inc. - ADR reported EPS of -$0.37, missing estimates by -3.24%, and revenue of $0.00, 0% as expectations.
How did the market react to Structure Therapeutics Inc. - ADR's Q3 2025 earnings?
The stock price moved down -1.88%, changed from $33.47 before the earnings release to $32.84 the day after.
When is Structure Therapeutics Inc. - ADR expected to report next?
The next earning report is scheduled for ٢٥ فبراير ٢٠٢٦.
What are the forecasts for Structure Therapeutics Inc. - ADR's next earnings report?
Based on 16
analysts, Structure Therapeutics Inc. - ADR is expected to report EPS of -$0.40 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان